Table 1 Detailed ALS patient and specimen data.

From: Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients

Patient (Number)

Sex

Age at onset (years)

Age at biopsy (years)

Site of onset

Familiar recurrence

Time from onset to biopsy (months)

Patients stratification based on duration of disease at biopsy

Site of biopsy

MRC score*

ALSFRS-R**

Disease duration (months)

Patients stratification based on evolution of the disease

Gene mutation

Gene expression

MicroRNAs expression

Cell Cultures

Protein expression

Histology

1

F

50

NA

Spinal

Sporadic

NA

NA

Deltoid

F = 0

NA

134 (T)

slow

Negative

x

x

  

x

2

F

70

71

Spinal

Sporadic

13

late

Quadriceps

F = 5

33/48

30 (D)

rapid

Negative

x

x

  

x

3

M

69

71

Spinal

Sporadic

18

late

Deltoid

NA

NA

16 (T)

rapid

Negative

x

x

  

x

4

M

63

63

Spinal

Sporadic

7

early

Quadriceps

F = 5

36/48

28 (D)

rapid

Negative

x

   

x

5

M

65

65

Spinal

Sporadic

6

early

Deltoid

F = 3

42/48

59 (D)

slow

Negative

x

x

   

6

M

43

43

Spinal

Sporadic

9

early

NA

NA

37/48

14 (LF)

NA

Negative

x

x

   

7

F

59

59

Spinal

Sporadic

10

early

Quadriceps

F = 5

42/48

58 (D)

slow

C9ORF72

x

x

  

x

8

F

54

55

Bulbar

Sporadic

19

late

Deltoid

F = 5

43/48

39 (D)

rapid

Negative

x

x

  

x

9

M

50

53

Spinal

Familial

28

late

Quadriceps

F = 5

41/48

48 (A)

slow

Negative

x

x

x

x

x

10

F

28

30

Spinal

Sporadic

26

late

Quadriceps

F = 5

41/48

48 (A)

slow

Negative

x

x

x

x

 

11

M

69

70

Bulbar

Sporadic

13

late

Quadriceps

F = 4

23/48

12 (T)

rapid

Negative

x

x

x

x

x

12

F

51

54

Spinal

Sporadic

36

late

Quadriceps

NA

NA

52 (A)

slow

Negative

x

x

x

  

13

F

55

56

Spinal

Familial

14

late

Quadriceps

F = 3

43/48

25 (A)

NA

C9ORF72

x

 

x

x

 

14

F

57

57

Spinal

Familial

13

late

Quadriceps

F = 5

46/48

18 (A)

NA

SOD1 L84F

x

x

x

x

 
  1. *The MRC score was referred to the muscle at biopsy and ranged from 0 (no visible movement) to 5 (normal muscle strength). **ALSFRS-R scores, at the time of muscle biopsy, ranged from 0 (total disability) to 48 (no disability). F = female; M = male; NA = not available; T = invasive mechanical ventilation by tracheotomy; D = dead; LF = lost at follow-up; A = alive.